Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that the Company’s CEO Dr. Stuart Titus was featured in global financial news outlet Reuters discussing the impact of COVID-19 on the cannabis industry.” data-reactid=”12″>SAN DIEGO, March 26, 2020 /PRNewswire/ — Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that the Company’s CEO Dr. Stuart Titus was featured in global financial news outlet Reuters discussing the impact of COVID-19 on the cannabis industry.
As customers hoard pot brownies, North American weed firms see lockdown boost," provided coverage of a recent surge in cannabis sales during the COVID-19 pandemic and quoted Titus as saying: "We have seen stockpiling in Canada by consumers who have snapped up products from LPs (licensed producers)."” data-reactid=”13″>The March 25, 2020, Reuters article entitled “As customers hoard pot brownies, North American weed firms see lockdown boost,” provided coverage of a recent surge in cannabis sales during the COVID-19 pandemic and quoted Titus as saying: “We have seen stockpiling in Canada by consumers who have snapped up products from LPs (licensed producers).”
Canada are seeing a sharp increase in sales, including a 50 percent spike across “key U.S. markets” from March 16 to March 22 alone.
80 to 100 percent," Titus said.” data-reactid=”15″>”Cannabis sales have increased substantially in Canada in recent weeks with some cannabis retailers even reporting growth of 80 to 100 percent,” Titus said.
The article was picked up by several leading global news outlets, including:
We are a company of firsts®. Medical Marijuana, Inc. (MJNA) is a cannabis company with three distinct business units in the non-psychoactive cannabinoid space: a global portfolio of cannabinoid-based nutraceutical brands led by Kannaway® and HempMeds®; a pioneer in sourcing the highest-quality legal non-psychoactive cannabis products derived from industrial hemp; and a cannabinoid-based clinical research and botanical drug development sector led by its pharmaceutical investment companies and partners including AXIM® Biotechnologies, Inc. and Kannalife, Inc. Medical Marijuana, Inc. was named a top CBD producer by CNBC. Medical Marijuana, Inc. was also the first company to receive historic import permits for CBD products from the governments of Brazil, Mexico, Argentina, and Paraguay and is a leader in the development of international markets. The company’s flagship product Real Scientific Hemp Oil has been used in several successful clinical studies throughout Mexico and Brazil to understand its safety and efficacy.” data-reactid=”22″>About Medical Marijuana, Inc.
We are a company of firsts®. Medical Marijuana, Inc. (MJNA) is a cannabis company with three distinct business units in the non-psychoactive cannabinoid space: a global portfolio of cannabinoid-based nutraceutical brands led by Kannaway® and HempMeds®; a pioneer in sourcing the highest-quality legal non-psychoactive cannabis products derived from industrial hemp; and a cannabinoid-based clinical research and botanical drug development sector led by its pharmaceutical investment companies and partners including AXIM® Biotechnologies, Inc. and Kannalife, Inc. Medical Marijuana, Inc. was named a top CBD producer by CNBC. Medical Marijuana, Inc. was also the first company to receive historic import permits for CBD products from the governments of Brazil, Mexico, Argentina, and Paraguay and is a leader in the development of international markets. The company’s flagship product Real Scientific Hemp Oil has been used in several successful clinical studies throughout Mexico and Brazil to understand its safety and efficacy.
OTCMarkets.com or by visiting www.medicalmarijuanainc.com. To see Medical Marijuana, Inc.’s corporate video, click here.” data-reactid=”23″>Medical Marijuana, Inc.’s headquarters is in San Diego, California, and additional information is available at OTCMarkets.com or by visiting www.medicalmarijuanainc.com. To see Medical Marijuana, Inc.’s corporate video, click here.
buy CBD oil and other products at Medical Marijuana, Inc.’s shop.” data-reactid=”24″>Shareholders and consumers are also encouraged to buy CBD oil and other products at Medical Marijuana, Inc.’s shop.
andrew.hard@cmwmedia.com
www.cmwmedia.com” data-reactid=”28″>CONTACT:
Public Relations Contact:
Andrew Hard
Chief Executive Officer
CMW Media
P. 858-264-6600
andrew.hard@cmwmedia.com
www.cmwmedia.com
Investors@medicalmarijuanainc.com” data-reactid=”29″>Investor Relations Contact:
P. (858) 283-4016
Investors@medicalmarijuanainc.com
http://www.prnewswire.com/news-releases/medical-marijuana-inc-ceo-featured-in-reuters-coverage-highlighting-the-impact-of-covid-19-on-cannabis-industry-301030044.html” data-reactid=”41″>View original content:http://www.prnewswire.com/news-releases/medical-marijuana-inc-ceo-featured-in-reuters-coverage-highlighting-the-impact-of-covid-19-on-cannabis-industry-301030044.html
SOURCE Medical Marijuana, Inc.
Recent Comments